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Gender differences among PWIDwith regards to
HIV transmission risk in St. Petersburg, Russia
Natalia Gnatienko5,∗, Judith Tsui2,
Jennifer A. Wagman3, Debbie M. Cheng4,
Anita Raj3, Elena Blokhina1, Olga Toussova1,
Leah Forman4, Dmitry Lioznov1,
Jeffrey H. Samet4,5
1 First Pavlov State Medical University of St.
Petersburg, St. Petersburg, Russian Federation
2 University of Washington, Seattle, WA, United
States
3 University of California, San Diego, CA, United
States
4 Boston University, Boston, MA, United States
5 Boston Medical Center, Boston, MA, United States
Aims:TheHIVepidemic inRussia is drivenby injectiondruguse.
Among people who inject drugs (PWID) in global settings, women
usually have higher HIV prevalence than men. Using data from a
cohort of HIV-infected Russian PWID we examined whether gen-
der is associated with HIV transmission risk: drug and sexual risk
behaviors.
Methods: This study involved secondary analysis of data from
Russia ARCH, a longitudinal cohort of HIV-infected persons in
St. Petersburg, Russia. Current analyses were restricted to PWID
(injected prior to HIV diagnosis or in the past 30 days). The main
independent variable was gender. The primary outcomes were
sharing of injecting equipment and unprotected sex. Secondary
outcomes were alcohol use prior to sharing injecting equipment
and unprotected sex; and simultaneous reporting of drug and sex
risk behaviors. Analyses used logistic regression models.
Results: The mean age of the sample (N=294) was 33 (SD±5)
years, 22% had ≤9th grade education, 26% were female and the
medianCD4 cell countwas 470 (IQR: 304, 698). Sharing drug equip-
ment in past 30 days was reported by 18% of participants and
9% used alcohol prior to sharing; 48% reported unprotected sex
in past 90 days and 56% used alcohol prior to sex; 11% reported
recent simultaneous drug equipment sharing and unprotected sex.
Women had significantly higher odds of reporting unprotected sex
(AOR=3.04, 95% CI: 1.60–5.81, p=0.001), but not other risk behav-
iors.
Conclusions: Among HIV-infected Russian PWID, women had
significantly higher odds of unprotected sex in the past 90 days.
Better understanding ofHIV risk behaviors amongwomen andmen
who inject drugs can supportmore gender-tailoredHIV prevention
interventions.
Financial support: U01AA020780, U01AA021989,
U24AA020779, U24AA020778.
http://dx.doi.org/10.1016/j.drugalcdep.2016.08.209
Intravenous and smoked methamphetamine
produce different subjective and physiological
effects in women
Nicholas E. Goeders
LSU Health Sciences Center, Shreveport, LA, United
States
Aims: Methamphetamine (meth) is unique since women are as
likely to use meth as men are. But few studies have compared the
route of meth administration and the perceived subjective effects
of the drug. This study was designed to determine potential differ-
ences in the subjective effects of intravenously administered (IV)
meth when compared to other routes of administration in women
using unstructured interviews.
Methods: After obtaining IRB approval potential subjects were
recruited. A consent letter was provided for potential subjects to
read, but they were not required to sign it so that confidentiality
could be maintained. The inclusion criteria included being female,
over the age of 18, and with meth as their primary drug of choice.
When these unstructured interviews were completed, the inter-
view notes were searched for the emergence of common themes
regarding differences between IV and smoked or snorted meth
using grounded theory, whereby key points were extracted from
information contained in the interview notes.
Results: Fifty-sixwomen participated in the 2.5-year study. The
mean age of the subjectswas 34.5 (±10.2; range: 18 to 56). Twenty-
three women said that they would experience “vapors” following
an IV injection of meth, resulting in an immediate “cough” or a
“taste” of the drug. Of the 51 women who used meth IV, 45 (88%)
reported the perception of an immediate sexual feeling indistin-
guishable fromanorgasmfollowingan injectionof sufficientpurity.
None of the participants reported a similar response when they
smoked or snorted the drug. The subjects also reported several
additional subjective andphysiological responses only experienced
with IV meth.
Conclusions: The major finding of this study is that the IV
administration of meth produces subjective (and physiological)
responses that are readily perceived as different from the responses
experienced when meth is smoked or snorted. These differences
should be taken into account when treating female IV metham-
phetamine users. Potential mechanisms underlying these effects
will be discussed.
Financial support:Thisworkwas supportedby theDepartment
of Pharmacology, Toxicology & Neuroscience.
http://dx.doi.org/10.1016/j.drugalcdep.2016.08.210
Associations between non-traditional tobacco
product use and ADHD symptoms in adolescents
Nicholas Goldenson1,∗, Rubin Khoddam2,
Adam Leventhal1,2
1 Preventive Medicine, University of Southern
California, Los Angeles, CA, United States
2 Psychology, University of Southern California, Los
Angeles, CA, United States
Aims: While cigarette smoking is declining among U.S. ado-
lescents, there has been a dramatic increase in the initiation
and continued use of new and non-traditional tobacco prod-
ucts such as electronic cigarettes (e-cigarettes) and hookah
(water pipe). Previous research has shown that attention-deficit
hyperactivity disorder (ADHD) is an important risk factor for com-
bustible cigarette use among adolescents, yet there is little data
assessingpossible associations betweenADHDsymptoms andnon-
traditional tobacco products.
Methods: High school students in the Los Angeles area
(N=3383) completed longitudinal surveys assessing lifetime and
current use of e-cigarettes and hookah and ADHD symptoms at 2
timepoints. Logistic regression in repeated-measures, generalized-
linear mixed models assessed relations between standardized
scores of ADHD symptoms and measures of tobacco product use
after controlling for pertinent demographic, interpersonal and
substance-related covariates.
Results: Among teens who never used e-cigarettes, the odds of
reporting e-cigarette initiation increased by 23% with each 1 SD
increase in ADHD score (odds ratio [OR], 1.23 [95% CI, 1.0–1.5];
